PureTech Health plc (NASDAQ:PRTC - Get Free Report) shares gapped down prior to trading on Friday . The stock had previously closed at $26.94, but opened at $26.15. PureTech Health shares last traded at $26.15, with a volume of 144 shares traded.
PureTech Health Price Performance
The business has a 50-day simple moving average of $26.29 and a 200 day simple moving average of $23.45.
Institutional Trading of PureTech Health
An institutional investor recently bought a new position in PureTech Health stock. Jane Street Group LLC bought a new position in shares of PureTech Health plc (NASDAQ:PRTC - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 8,343 shares of the company's stock, valued at approximately $269,000. Hedge funds and other institutional investors own 0.04% of the company's stock.
PureTech Health Company Profile
(
Get Free Report)
PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
